initial public offerings (IPOs) trading on American exchanges
Showing posts with label lockup expirations. Show all posts
Showing posts with label lockup expirations. Show all posts

Monday, June 8, 2020

IPOs this week : June 8 - 12, 20 (wk 23)


IPOs expected to price
  • Online car seller Vroom (VRM) is offering about 18.8M shares in an expected range of $17 to $19. The timing for the IPO is intriguing with the pandemic leading to more online shopping for cars, but sales and margins under pressure. How well the Vroom IPO is received by investors could be of interest to Carvana (NYSE:CVNA), Cars.com (NYSE:CARS), TrueCar (NASDAQ:TRUE), AutoNation (NYSE:AN) and even Tesla (NASDAQ:TSLA) as the concept of online car shopping heads more mainstream. Vroom is expected to have a market capitalization of around $1.92B if it prices at the higher end of the indicated range. 
  • Across the Pacific, Chinese gaming company NetEase (NASDAQ:NTES) is looking to raise $1.2B in a Hong Kong listing to fund strategies for international expansion. Shares are expected to start trading on June 11. 

The quiet period expires for ADC Therapeutics (NYSE:ADCT) on June 9 and IPO share lockups end on XP (NASDAQ:XP), Bill Holdings (NYSE:BILL), OneConnect Financial (NYSE:OCFT) and Sprout Social (NASDAQ:SPT) later in the week.

There are also secondary offering lockup expirations on Tilray (NASDAQ:TLRY) and BlackRock (NYSE:BLK) to keep an eye on.

Tuesday, October 15, 2019

Pinterest (PINS) falls to four-month low as IPO lockup expires

  • From 10-Q: "Beginning on October 15, 2019, up to 537,853,460 shares of our common stock will be released from the 180-day lock-up entered into in connection with our initial public offering and will be eligible for sale in the public market, subject to applicable securities laws and any applicable quarterly trading restrictions."


Monday, September 30, 2019

IPOs this week : Sept 30 - Oct 4, 19 (wk 40)

IPOs expected to price
Five U.S. IPOs are expected to price on October 1, all on the smaller side ($40M to $245M). The companies set to debut are
  • ADC Therapeutics (ADCT) -- Swiss biotech that plans to raise $200 million at a $1.8 billion valuation. The company is developing antibody drug conjugates, and its pipeline consists of seven candidates targeting hematological malignancies and solid tumors. Its two lead candidates are in pivotal Phase 2 trials, one of which is in collaboration with Genmab (NASDAQ:GMAB).
  • Viela Bio (VIE), which is developing antibodies licensed from AstraZeneca, plans to raise $150 million at a $1.0 billion valuation. The company's lead candidate, inebilizumab, is a humanized monoclonal antibody designed to target CD19 for neuromyelitis optica spectrum disorder, a rare condition that attacks the nervous system. It could potentially be approved in the 1H20.
  • Frequency Therapeutics (FREQ), a generative disease biotech that plans to raise $101 million to command a $526 million market cap. Its lead candidate, FX-322, is being developed to treat sensorineural hearing loss, the permanent loss of sensory hair cells in the cochlea within the ear.
  • Aprea Therapeutics (APRE) and Monopar Therapeutics (MNPR) are both Phase 3 biotechs developing therapies for cancer;
  • Metrocity Bankshares (OTCQX:MCBS) is a Georgia bank focused on serving Asian-American communities in the Eastern US and Texas.
Meanwhile, Budweiser Brewing Company APAC (BUDBC) is due to begin trading in Hong Kong on September 30 under stock code 1876.
Also in Hong Kong, Topsports International will begin trading on October 2 in an IPO aimed at raising up to $1.2B. Topsorts is the sportswear business of Chinese footwear retailer Belle International (OTCPK:BELLF).

IPO lockup expirations
IPO lockup expirations arrive for
  • Ruhnn (NASDAQ:RUHN) and Powerbridge Technologies (NASDAQ:PBTS) on September 30, as well as for 
  • Tradeweb (NASDAQ:TW), Silk Road Medical (NASDAQ:SILK) and NGM Biopharmaceuticals (NASDAQ:NGM) on October 1.

Monday, August 12, 2019

IPOs this week : Aug 12 - 16, 19 (wk 33)

IPOs expected to price during the week include:
  • BioVie (OTCQB:BIVI) on August 12 and 
  • CrossFirst Bankshares (CFB) on August 14:  Kansas corporation and registered bank holding company with total assets of $4.5 bln [Planning to offer 7.11 mln shares between $15.00-17.00]
9F (NYSE: JFU): Leading digital financial account platform integrating and personalizing financial services in China [Planning to offer 8.9 mln ADS between $7.50-9.50]

WiMi Hologram Cloud (Nasdaq: WIMI): Provider of augmented reality-based holographic services and products [Planning to offer 4 mln shares between $7.50-9.50]

IPO quiet period expirations
  • Phreesia (NYSE:PHR), DouYu (NASDAQ:DOYU), Owl Rock Capital (NYSE:ORCC), Mirum Pharmaceuticals (NASDAQ:MIRM), Fulcrum Therapeutics (NASDAQ:FULC), Genmab (NASDAQ:GMAB), Assetmark Financial (NYSE:AMK) and First Seacoast Bancorp (FSEA) on August 12
  • Medallia (NYSE:MDLA), Afya (NASDAQ:AFYA) and Intercorp Financial (IFS) on August 13. 
IPO lockup expirations
  • There are also IPO expirations for TCR2 Therapeutics (NASDAQ:TCRR), Intercorp Financial (IFS) and Avedro (NASDAQ:AVDR) on August 13.

Saturday, August 3, 2019

IPOs this week : Aug 5 - 9, 19 (wk 32)

IPOs expected to price during the week include:
  • BioVie (OTCQB:BIVI) on August 6 
  • InMode (INMD) on August 7. 

IPO lockup expirations:
  • IPO share lockup expirations arrive on Alector (NASDAQ:ALEC) and ToughBuilt Industries (NASDAQ:TBLTU) on August 6, as well as 
  • Gossamer Bio (NASDAQ:GOSS) and Harpoon Therapeutics (NASDAQ:HARP) on August 7. 


Earnings:
A number of recent IPO companies are due to report earnings including

  • BioBie (OTCQB:BIVI), Farfetch (NYSE:FTCH), Sonos (NASDAQ:SONO), Eventbrite (NYSE:EB) and Revolve Group (NYSE:RVLV). 
Also bubbling right under the surface, Saudi Aramco (ARMCO) is reportedly restarting preparations to raise $100B by from selling a 5% stake. It could easily be the biggest IPO in history.

Monday, July 8, 2019

IPOs this week : July 8 - 12, 19

IPO share lockups arrive on

  • Mmtec (NASDAQ:MTC) and MDJM (NASDAQ:MDJH) on July 8. 

Analyst quiet period expirations on

  • Crowdstrike (NASDAQ:CRWD) and Fiverr (NYSE:FVRR) are also scheduled for July 8, 
  • while analysts involved in the IPO can start buzzing on Chewy (NYSE:CHWY) on July 9. 
CRWD, FVRR and CHWY all trade below their highs, but are all at least 30% over where their IPOs were priced.

Also of note next week, Anheuser-Busch InBev's (NYSE:BUD) listing of Budweiser Asia is expected to price in New York on July 11 before debuting in Hong Kong the following week. Anheuser-Busch is selling 1.6B primary shares between HKD$40 and HKD$47 hoping to raise $9.8B from the listing. The beer giant plans to pay down debt and the new entity could be in a better position to partner with local brewers such as ThaiBev (OTCPK:TBVPF) following the split.

Sunday, June 16, 2019

IPOs this week : June 17 - 21, 19

IPO watch:
  • Stoke Therapeutics (STOK) is expected to price its IPO on June 18, 
  • Akero Therapeutics (AKRO), Atreca (BCEL), Dermavant Sciences (DRMT), Grocery Outlet Holdings (GO), Personalis (PSNL) and Prevail Therapeutics (PRVL) are all slated to price on June 20.


IPO quiet period/lockup expirations: Quiet periods end on
  • Rattler Midstream (NASDAQ:RTLR), Ideaya Biosciences (NASDAQ:IDYA) and Bicycle Therapeutics (NASDAQ:BCYC) on June 17. 
  • Meanwhile, share lockups expire on Amarant (NASDAQ:AMTB), LiveXLive Media (NASDAQ:LIVX) and Datasea (NASDAQ:DTSS) on June 17 - as well as Cardiol Therapeutics (OTCPK:CRTPF) on June 18. 
  • Over in Tokyo, some shares of SoftBank Corp. (OTCPK:SOBKY) are also due to be freed up on June 17.
Spotlight on Slack:
Slack Technologies (WORK) expects to be valued by investors at $16B to $17B when the workspace chat/collaboration software company lists shares on June 20 in a direct listing. For the fiscal year ending in January, Slack expects to churn up revenue of $590M (+50% Y/Y) but estimates for the bottom line vary widely. Per public filings, Slack's shares have traded at prices ranging from $8.37 to $31.50 per share in the private market.

Monday, June 10, 2019

IPOs this week : June 10 - 14, 19

 IPO watch: 

Crowdstrike (CRWD), Fiverr International (FVRR) and Chewy (CHWY) are all expected to price this week amid what's been a hit or miss IPO market.

  • Cybersecurity specialist Crowdstrike already boosted the top end of its pricing range by 30% amid strong demand. 
  • Meanwhile, Gig-economy player Fiverr is hoping to follow in the path of competitor Upwork (NASDAQ:UPWK) with a huge first-day pop. 
  • Online pet food seller Chewy is looking to raise over $100M with its offering at a proposed valuation of over $7B. Chewy's revenue grew 75% in FY18 to $3.5B and the company recorded a net loss of $267M. Owner PetSmart will still own 70% of the total Chewy shares outstanding and 77% of the voting power following the IPO. 
In Hong Kong, Anheuser-Busch InBev (NYSE:BUD) is looking for listing approval for Budweiser Brewing Company APAC.

IPO quiet period/lockup expirations:
  • There are share price lockup expirations arriving on Tencent Music (NYSE:TME) on June 10 and both Legacy Housing (NASDAQ:LEGH) and 360 Finance (NASDAQ:QFIN) on June 11. 
  • Quiet period expirations on tap include Applied Therapeutics (NASDAQ:APLT) and Postal Realty Trust (NYSE:PSTL) on June 10, as well as Avantor (NYSE:AVTR), Luckin Coffee (NASDAQ:LK) and Fastly (NYSE:FSLY) on June 11.

Sunday, June 2, 2019

IPOs this week : June 3 - 7, 19 (wk 23)

Analyst quiet period expirations: 
  • Trevi Therapeutics (NASDAQ:TRVI), 
  • Parsons (NYSE:PSN), 
  • HeadHunter (NASDAQ:HHR), 
  • Axcella Health (NASDAQ:AXLA), 
  • NextCure (NASDAQ:NXTC), 
  • Mayville Engineering (NYSE:MEC), 
  • Milestone Pharma (NASDAQ:MIST), 
  • South Plains Financial (NASDAQ:SPFI) and 
  • Cortexyme (NASDAQ:CRTX) on June 3; 
  • Sonim Technologies (NASDAQ:SONM) and 
  • Jiayin (NASDAQ:JFIN) on June 4.

IPO share lockup expirations:
  • Mogu (NYSE:MOGU) on June 4; 
  • Moderna (NASDAQ:MRNA), 
  • Synthorx (NASDAQ:THOR) and DiaMedica (NASDAQ:DMAC) on June 5.

Monday, April 22, 2019

IPOs this week : April 22 - 26, 19


Expected IPO pricings: No new pricings are on the calendar for next week after a sizzling week for new offerings. In case you missed it, Pinterest (NYSE:PINS) jumped 28% on its first day of trading, while Zoom Video Communications (NASDAQ:ZM) topped that performance with a 72% rip.

IPO lockup expirations:

  • Yeti (NYSE:YETI), StoneCo (NASDAQ:STNE) and Pintec Technology (NASDAQ:PT) see lockups expire on April 23. Yeti is the one that might see some insider selling with shares up 119% YTD.


IPO quiet period expirations:

  • Genfit (NASDAQ:GNFT) and Precision BioSciences (NASDAQ:DTIL) on April 22; 
  • Lyft (NASDAQ:LYFT) on April 23.

Monday, April 15, 2019

IPOs this week : April 15 - 19, 19

Expected IPO pricings: 
  • A big week is on tap for IPO pricings, led by Pinterest (PINS) which has set a pricing target of $15 to $17 to bring in around $1.2B and value the company at around $9B. Pinterest saw revenue jump 60% last year to $756M and is projected to see 45% growth this year to about $1.1B. 
  • Other pricing during the week include Palomar (PLMR) and Brainsway (BWAY) on April 16 
  • as well as Zoom Video Communications (ZM), Brigham Minerals (MNRL), Turning Point Therapeutics (TPTX) and Hookipa Pharmaceuticals (HOOK) on April 17.

IPO lockup expirations: 
  • SI-Bone (NASDAQ:SIBN) on April 15; 
  • Osmotica Pharmaceuticals (NASDAQ:OSMT), Studio City (NYSE:MSC) and PhaseBio Pharmaceuticals (NASDAQ:PHAS) on April 16; 
  • LogicBio Therapeutics (NASDAQ:LOGC), Niu Technologies (NASDAQ:NIU) and SolarWinds (NYSE:SWI) on April 17.

IPO quiet period expirations: 
Analysts will start buzzing about Levi Strauss (NYSE:LEVI) on April 15. Levi's priced its IPO at $17, above the target range of $14 to $16. Shares closed at $22.22 on Friday. It doesn't appear that Levi's management is getting ahead itself after the company posted a solid Q4 and seeing the share price bounce. "We're still facing some headwinds, including anticipated door closures at traditional wholesale customers, unrest in Europe, as well as Brexit, continued uncertainty around China tariffs, and declines in U.S. retail traffic," stated CEO Chip Bergh on the earnings call.

Monday, April 1, 2019

IPOs this week : April 1 - 5, 19 (wk 14)

Expected IPO pricings:
  • Ruhnn Holding (RUHN) on April 2; 
  • Silk Road Medical (SILK), NGM Biopharmaceuticals (NGM) and Tradeweb Markets (TW) on April 3.

IPO lockup expirations:
  • Upwork (NASDAQ:UPWK) and Guardant Health (NASDAQ:GH) on April 1; 
  • Kodiak Sciences (NASDAQ:KOD) on April 2; 
  • Elastic (NYSE:ESTC) on April 3.

IPO quiet period expirations:
  • Shockwave Medical (NASDAQ:SWAV) on April 1 and 
  • Futu (NASDAQ:FHL) on April 2.

Sunday, March 24, 2019

IPOs this week : March 25 - 29, 2019

IPO pricings: Lyft (LYFT) is the elephant in the IPO room, set to price on March 28 and make its trading debut the next day. It has a marketed range of $62-$68/share for a valuation up to $23B. Lyft is getting out ahead of ride-sharing rival Uber, which is now expected to file next month for a behemoth listing of $120B.
Also pricing:
  • Genfit SA (GNFT) on March 26. 
  • Precision Biosciences (DTIL) and 8I Enterprises Aquisition Corp. (JFKKU) on March 27.

IPO lockup expirations:
  • Arco Platform (NASDAQ:ARCE), Capital Bancorp (NASDAQ:CBNK), Entasis Therapeutics Holdings (NASDAQ:ETTX), SVMK (NASDAQ:SVMK), and Viomi Technology (NASDAQ:VIOT) on March 25. 
  • Arvinas (NASDAQ:ARVN), Laix (NYSE:LAIX), RA Medical Systems (NYSE:RMED), Sutro Biopharma (NASDAQ:STRO) and Urovant Sciences (NASDAQ:UROV) on March 26. 
  • CooTek Cayman (NYSE:CTK) and Gritstone Oncology (NASDAQ:GRTS) on March 27.

IPO quiet period expirations:
  • Kaleido Biosciences (NASDAQ:KLDO), Anchiano Therapeutics (NASDAQ:ANCN) and Imac Holdings (NASDAQ:IMAC) on March 25. 
  • Avedro (NASDAQ:AVDR) and TCR2 Therapeutics (NASDAQ:TCRR) on March 26. 
  • Hoth Therapeutics (NASDAQ:HOTH) and Stealth Biotherapeutics (NASDAQ:MITO) on March 27.

Sunday, March 17, 2019

IPOs this week : March 18 - 22, 2019

IPO pricings: 
  • Up Fintech (TIGR) is expected to price its offering on March 19. 
  • In a notable deal for the apparel sector, Levi Strauss (LEVI) is expected to price its IPO on March 20. The iconic company is offering 36.7M shares in an expected range of $14 to $16. The timing could be good for the Levi Strauss IPO after American Eagle Outfitters (NYSE:AEO) and Abercrombie & Fitch (NYSE:ANF) both cited strong demand for denim products in their Q4 earnings reports. 
  • Alight (ALIT) is pricing its IPO on March 21, 
  • while across the Pacific, luxury auto specialist Shanghai Dongzheng Automotive is due to price 533M shares in an expected range of HK$4.20 to HK$6.30. 

IPO lockup expirations: 
  • Aptorum (NASDAQ:APM) and X Financial (NYSE:XYF) on March 18; 
  • Bank7 (NASDAQ:BSVN), Eventbrite (NYSE:EB) and Elanco Animal Health (NYSE:ELAN) on March 19; 
  • Farfetch (NYSE:FTCH), Y-mAbs Therapeutics (NASDAQ:YMAB) and Golden Bull (NASDAQ:DNJR) on March 20.

Sunday, March 10, 2019

IPOs this week : March 11 - 15, 2019

IPO activity: The six-month lockup on shares of Nio (NYSE:NIO) expires on March 11 in what should be a good test of investor sentiment. Nio soared following a positive 60 Minutes piece about two weeks ago before going into post-earnings skid. Interestingly, Goldman Sachs came in with a reinstated Buy call on Nio ahead of the lockup expiration as it pointed to the Chinese automaker's "successful branding" in the premium segment.

Other lockup expirations this week include;

  • 111 (NASDAQ:YI) on March 11, 
  • FVC Bancorp (NASDAQ:FVCB) on March 12 and 
  • both Principia Biopharma (NASDAQ:PRNB) and Qutoutiao (NASDAQ:QTT) on March 13. 
Analysts can start covering TCR2 Therapeutics (NASDAQ:TCRR), Avedro (NASDAQ:AVDR), Achiano Therapeutics (NASDAQ:ANCN) and Imac (NASDAQ:IMAC) on March 11 and Stealth BioTherapeutics (NASDAQ:MITO) on March 12.

Saturday, February 9, 2019

IPOs this week : Feb. 11 - 15, 2019

IPOs expected to price:

  • Anchiano Therapeutics (ANCN) on February 11; 
  • Virgin Trains USA (VTUS) on February 12; 
  • TCR2 Therapeutics (TCRR)
  • Cibus (CBUS) and Avedro (AVDR) on February 13; 
  • Stealth BioTherapeutics (MITO) on February 14.


IPO activity: In case you missed it, the IPO market was lit up with the news that Postmates (POSTM) and Slack (SLACK) filed for confidential listings.

There are IPO share lock-up expirations upcoming on Avalon GloboCare (OTCQB:AVCO) and Aridis Pharmaceuticals (NASDAQ:ARDS) on February 12 and Safe-T (NASDAQ:SFET) on February 13.

Sunday, January 20, 2019

IPOs this week : Jan. 21-25, 2019 (wk 4)

No companies are expected to price their IPOs this week, but there are plenty of share lockup expirations to keep an eye on.

Lockups expire on 
  • Pinduoduo (NASDAQ:PDD), Provention Bio (NASDAQ:PRVB), Bloom Energy (NYSE:BE), Berry Petroleum (NASDAQ:BRY), Cango (NYSE:CANG), Aurora Mobile (NASDAQ:JG), Focus Financial (NASDAQ:FOCS), Tenable (NASDAQ:TENB) and Liquidia Technologies (NASDAQ:LQDA) on January 22.
  • Adial Pharmaceuticals (NASDAQ:ADIL), Endava (NYSE:DAVA), Summit Wireless Technologies (WISA) and Opera (NASDAQ:OPRA) on January 23.

Tuesday, May 6, 2014

Twitter shares hit new lows as stock lock-up expires

  • Shares of Twitter Inc sank 18 percent to a new low in frenzied trading on Tuesday, wiping out more than $4 billion of its market value, as early investors sold stock in the messaging service for the first time after a six-month "lock-up" expired.
  • The lock-up agreement that expired this week applied to about 470 million shares, or 82 percent of Twitter's equity, held by insiders, venture capitalists and other investors. Twitter allowed one batch of shares to be sold in February, but that lockup governed only about 10 million shares, most of which were held by non-executive employees.
  • Tuesday's reaction to Twitter's lock-up expiry was in sharp contrast to that of Facebook Inc in late 2012. Facebook shares jumped 13 percent on November 14 that year, when its lock-up expiry of roughly 800 million shares did not trigger an immediate wave of insider selling.
  • Twitter's shares have been trading at all-time lows since April 29, when the company disclosed sagging usage metrics.  Indeed, concerns about user growth and engagement levels have wiped out about half of Twitter's market value, more than $18 billion, since late December, even as it has hit revenue targets in the two quarters since it went public at $26 a share.

Until Tuesday, only about 80 million Twitter shares, a fraction of outstanding shares, were publicly traded. About 500 million closely held shares were unlocked for possible trades late Monday. They hit the market at Tuesday's opening bell.

This week's lock-up is the second and by far the largest lock-up period for Twitter, which also freed about 9.9 million shares held by non-executive employees on Feb. 15. The company sold about 70 million shares in its November 2013 initial public offering.

Vijaya Gadde, Twitter's general counsel, sold 3,914 shares on Tuesday at $39.09 apiece, according to a regulatory filing. Vice President of Engineering Christopher Fry sold 19,568 shares at the same price, according to another regulatory filing. Both still hold many shares, with Gadde's holdings totaling 861,642 shares and Fry's at 949,181 following their sales.

Several executives, including CEO Richard Costolo, said in an April 14 regulatory filing that they don't have "current plans" to sell shares.

"This should, arguably, help alleviate some of the potential pressure on the stock in the coming weeks," wrote Sterne Agee analyst Arvind Bhatia in a research note before the lock-up ended.

But Twitter stock nonetheless fell more than 16% to about 32.35 by late afternoon on the stock market today. The stock's trading about 57% off its all-time high of 74.73 on Dec. 26.

Tuesday's trading volume flew north of 100 million shares in late-afternoon trading, about 8x the company's daily average of 13.2 million shares.

Wednesday, December 18, 2013

Gogo (GOGO) shares drop 15% as IPO lockup period ends


Gogo Inc. shares dropped sharply today as lockup restrictions on the stock expired and one of its largest investors, a private-equity fund, distributed shares to its limited partners.


Gogo's stock fell 13 percent to about $27 this morning. But the stock, which had a slow start after going public in June, was up 81 percent from its $17 IPO price before today, when Ripplewood Holdings announced the distribution of shares to its own stockholders.

New York-based Ripplewood, which invested in Gogo in 2006, owns 38 percent of the company's stock. Lockup restrictions, which prevent insiders from trading or distributing their shares for a predetermined period after an IPO, expired. But it will be up to Ripplewood shareholders to decide whether to sell their Gogo shares.

"This share distribution was made to provide our limited partners with greater flexibility to achieve liquidity," Ripplewood founder Timothy Collins said in a statement. "We continue to believe that Gogo has a very bright future as a leader and pioneer in the in-flight connectivity and digital entertainment solutions markets, and we have been extremely pleased by the performance of the company and the success of our investment in Gogo."

Gogo, based in Itasca, provides in-flight Wi-Fi and entertainment on commercial planes, including Delta and American Airlines. The company, formerly known as Aircell, was founded in 1991 and took a lot of time and money to get off the ground.

Gogo's second-largest shareholder, Oakleigh Thorne, holds about 29 percent of the company's stock.